Skip to main content
Premium Trial:

Request an Annual Quote

Beyond Genomics Embarks on Toxicology Pilot Project for AstraZeneca

NEW YORK, Feb. 3 (GenomeWeb News) - Beyond Genomics will embark on a pilot project with AstraZeneca to discover markers of drug-induced toxicity, the company said today.


In the study, Beyond Genomics, of Waltham, Mass., will use its systems biology approaches to analyze transcript, protein, and metabolite data.


Last month, Beyond Genomics signed a research deal with GlaxoSmithKline, resulting from a pilot study that started at the end of 2002.


The Scan

US Booster Eligibility Decision

The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions.

Arizona Bill Before Judge

The Arizona Daily Star reports that a judge is weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction.

Additional Genes

Wales is rolling out new genetic testing service for cancer patients, according to BBC News.

Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification

In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.